315 related articles for article (PubMed ID: 38659000)
1. Ferroptosis in heart failure.
Yang X; Kawasaki NK; Min J; Matsui T; Wang F
J Mol Cell Cardiol; 2022 Dec; 173():141-153. PubMed ID: 36273661
[TBL] [Abstract][Full Text] [Related]
2. Research advances on molecular mechanism and natural product therapy of iron metabolism in heart failure.
Zhang T; Luo L; He Q; Xiao S; Li Y; Chen J; Qin T; Xiao Z; Ge Q
Eur J Med Res; 2024 Apr; 29(1):253. PubMed ID: 38659000
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis: Emerging Role in Diseases and Potential Implication of Bioactive Compounds.
Patanè GT; Putaggio S; Tellone E; Barreca D; Ficarra S; Maffei C; Calderaro A; Laganà G
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139106
[TBL] [Abstract][Full Text] [Related]
4. Future Perspectives of Oxytosis/Ferroptosis Research in Neurodegeneration Diseases.
Viktorinova A
Cell Mol Neurobiol; 2023 Aug; 43(6):2761-2768. PubMed ID: 37093436
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review.
Zhao D; Yang K; Guo H; Zeng J; Wang S; Xu H; Ge A; Zeng L; Chen S; Ge J
Biomed Pharmacother; 2023 Aug; 164():114312. PubMed ID: 37210894
[TBL] [Abstract][Full Text] [Related]
6. Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products.
Yang K; Zeng L; Zeng J; Deng Y; Wang S; Xu H; He Q; Yuan M; Luo Y; Ge A; Ge J
Ageing Res Rev; 2023 Nov; 91():102063. PubMed ID: 37673132
[TBL] [Abstract][Full Text] [Related]
7. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis.
Melenovsky V; Petrak J; Mracek T; Benes J; Borlaug BA; Nuskova H; Pluhacek T; Spatenka J; Kovalcikova J; Drahota Z; Kautzner J; Pirk J; Houstek J
Eur J Heart Fail; 2017 Apr; 19(4):522-530. PubMed ID: 27647766
[TBL] [Abstract][Full Text] [Related]
8. Zooming in and out of ferroptosis in human disease.
Wang X; Zhou Y; Min J; Wang F
Front Med; 2023 Apr; 17(2):173-206. PubMed ID: 37121959
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity.
Wang Y; Ying X; Wang Y; Zou Z; Yuan A; Xiao Z; Geng N; Qiao Z; Li W; Lu X; Pu J
Cell Signal; 2023 Jul; 107():110655. PubMed ID: 36924813
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan Reverses Cardiac Malfunction and Cardiomyocyte Ferroptosis During Heart Failure with Preserved Ejection Fraction via Connexin 43 Signaling Activation.
Zhang LL; Chen GH; Tang RJ; Xiong YY; Pan Q; Jiang WY; Gong ZT; Chen C; Li XS; Yang YJ
Cardiovasc Drugs Ther; 2023 Mar; ():. PubMed ID: 36881213
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV, as a potential anticancer agent.
Xia D; Li W; Tang C; Jiang J
Front Pharmacol; 2023; 14():1065505. PubMed ID: 36874003
[TBL] [Abstract][Full Text] [Related]
12. Nanoencapsulation of Cyanidin 3-
Zannou O; Oussou KF; Chabi IB; Awad NMH; Aïssi MV; Goksen G; Mortas M; Oz F; Proestos C; Kayodé APP
Nanomaterials (Basel); 2023 Feb; 13(3):. PubMed ID: 36770579
[TBL] [Abstract][Full Text] [Related]
13. Idebenone attenuates ferroptosis by inhibiting excessive autophagy via the ROS-AMPK-mTOR pathway to preserve cardiac function after myocardial infarction.
Li D; Zhang G; Wang Z; Guo J; Liu Y; Lu Y; Qin Z; Xu Y; Cao C; Wang B; Guo Q; Wang Y; Liu G; Cui X; Zhang J; Tang J
Eur J Pharmacol; 2023 Mar; 943():175569. PubMed ID: 36740037
[TBL] [Abstract][Full Text] [Related]
14. The antioxidant glutathione.
Averill-Bates DA
Vitam Horm; 2023; 121():109-141. PubMed ID: 36707132
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
